Year To Quarter End Statement Of Income

BrightPath Biotherapeutics Co., Ltd. - Filing #7722100

Concept 2018-04-01 to
2018-06-30
2017-04-01 to
2017-06-30
Year to quarter end statement of income
Statement of income
Net sales
122,129,000 JPY
90,638,000 JPY
Cost of sales
62,230,000 JPY
87,836,000 JPY
Gross profit (loss)
59,898,000 JPY
2,801,000 JPY
Selling, general and administrative expenses
457,556,000 JPY
264,874,000 JPY
Selling, general and administrative expenses
Operating profit (loss)
-397,657,000 JPY
-262,073,000 JPY
Non-operating income
Non-operating income
98,000 JPY
12,000 JPY
Non-operating expenses
Non-operating expenses
1,548,000 JPY
80,000 JPY
Ordinary profit (loss)
-399,107,000 JPY
-262,140,000 JPY
Extraordinary losses
Impairment losses
182,818,000 JPY
JPY
Extraordinary losses
182,818,000 JPY
JPY
Profit (loss) before income taxes
-581,925,000 JPY
-262,140,000 JPY
Income taxes - current
962,000 JPY
1,647,000 JPY
Income taxes - deferred
466,000 JPY
825,000 JPY
Income taxes
1,428,000 JPY
2,472,000 JPY
Profit (loss)
-583,354,000 JPY
-264,612,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.